1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Severe Asthma: new trials by email Literature Review of Severe Asthma trials Research Report on Severe Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects Mepolizumab Injection (BAT2606 Injection), Mepolizumab Injection (EU-licensed Nucala), Mepolizumab Injection (US-licensed Nucala) - Severe Asthma | Phase 1 | Completed | Bio-Thera Solutions | 207 | 2022-09-20 | 2023-08-28 |
Asthma (1)
Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1)
mepolizumab (1)
China (1)
Yanhua Ding, PhD (1)